Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Pediatr Res. 2010 Jul;68(1):29–34. doi: 10.1203/PDR.0b013e3181e12770

Fig. 8.

Fig. 8

The percent change in NOS enzymatic activity in afferent arterioles (as measured by enzymatic assay) in controls (●) and after treatment with ANG II (■), ANG II with candesartan (AT1X: ▲) or ANG II with PD 123319 (AT2X ◆). *P<0.05, vs. control (all ages); P<0.05, vs. AT1X.